Diamond Quantum Sensors Detect Immune Cell Inflammation Through Electric Charge Shifts

Why It Matters

The ability to track immune‑cell activation electrically, without destroying the cell, offers a new quantitative tool for immunology and cancer research, accelerating drug discovery and precision oncology.

Key Takeaways

• NV‑diamond probes sense intracellular electric fields, not temperature
• Bare nanodiamonds show ZFS drift; silica shells suppress it
• Charge‑transfer signal correlates with macrophage inflammatory activation
• Method enables real‑time, label‑free single‑cell monitoring
• Platform may extend to T‑cell killing assays in oncology

Pulse Analysis

The rise of quantum‑enabled biosensing has been anchored by nitrogen‑vacancy (NV) centers in diamond, whose spin states react to magnetic, thermal, and electric perturbations. While NV ensembles have delivered magnetic imaging of bacteria and neuronal action potentials, their utility inside living cells has been hampered by random crystal orientations that cancel electric‑field signals, leaving researchers to interpret zero‑field splitting (ZFS) shifts as temperature changes. This ambiguity has limited the technique to endpoint assays, preventing continuous, label‑free observation of dynamic cellular processes such as immune activation.

The University of Chicago‑Iowa team solved the orientation problem by adding a secondary transverse dipole term, d′, to the NV Hamiltonian. Unlike the primary dipole, d′ survives ensemble averaging and produces a quadratic frequency shift proportional to the local electric field generated when surface charges exchange with the surrounding medium. Experiments with 70 nm bare nanodiamonds in phosphate‑buffered saline recorded a reproducible −0.45 MHz ZFS drift, whereas silica‑coated core‑shell particles remained stable within a 0.85 kHz noise floor. The charge‑transfer origin was confirmed by lysate‑only measurements and by the absence of temperature‑consistent heating estimates.

By converting what was previously dismissed as noise into a quantitative read‑out, the approach opens a pathway to real‑time, single‑cell immunomonitoring without fluorescent labels or cell lysis. Detecting the −0.27 MHz ZFS shift in LPS‑stimulated macrophages translates to a ~450 mV surface‑potential change, directly linking metabolic stress to immune signaling. The dual advantage of core‑shell protection—reducing cytotoxicity while preserving thermometric fidelity—makes the platform attractive for drug‑screening pipelines and for tracking T‑cell mediated tumor killing in vivo. As quantum sensor fabrication scales, the technology could become a staple in precision oncology and systems immunology.